[HTML][HTML] Clinical and microbiological features and outcomes of mucormycosis in critically ill patients

K Rothe, K Braitsch, R Okrojek, M Heim… - International Journal of …, 2021 - Elsevier
Introduction Mucormycosis is a rare invasive fungal infection with high mortality in patients
with severe underlying predisposing factors causing immunosuppression. The exact …

Letermovir prophylaxis for CMV reactivation in allogeneic stem cell recipients: a retrospective single center analysis

K Koch, L Osswald, I Miller, K Braitsch… - Anticancer …, 2022 - ar.iiarjournals.org
Background/Aim: Cytomegalovirus (CMV) reactivation is one of the most clinically significant
complications in allogeneic stem cell recipients and a frequent cause for transplantation …

[HTML][HTML] Conditioning with fludarabine and treosulfan compared to FLAMSA-RIC in allogeneic stem cell transplantation for myeloid malignancies: a retrospective …

K Braitsch, A Schwarz, K Koch, M Hubbuch… - Annals of …, 2022 - Springer
Reduced intensity conditioning (RIC) and reduced toxicity conditioning (RTC) regimens
enable allogeneic hematopoietic stem cell transplantation (alloSCT) to more patients due to …

Der Einfluss von Therapie und zytogenetischen Veränderungen auf die Interaktion mit dem Tumormikroenvironment bei Patienten mit chronisch lymphatischer …

KO Braitsch - 2023 - mediatum.ub.tum.de
Um die" environment mediated drug resistance" bei Patienten mit CLL im Verlauf der Erkrankung
besser zu verstehen, wurden 65 sequentielle CLL Proben von 24 Patienten in einem …

[PDF][PDF] Fakultät für Medizin

KO Braitsch - 2023 - d-nb.info
Die chronisch lymphatische Leukämie (CLL) ist eine reife B-Zell Neoplasie und gilt als
häufigste Leukämie Form bei Erwachsenen im mitteleuropäischen Raum. Die Erkrankung …

[HTML][HTML] Combination Treatment of Venetoclax and Hypomethylating Agents (HMA) or Low-Dose Cytarabine (LDAC) for Patients with Acute Myeloid Leukemia (AML) …

LK Schmalbrock, K Braitsch, P Jung, I Bumeder… - Blood, 2021 - Elsevier
Introduction Treatment with the BCL-2 inhibitor Venetoclax (VEN) in combination with
hypomethylating agents (HMA) or low-dose cytarabine (LDAC) has shown encouraging results in …

[HTML][HTML] A diagnostic algorithm for detection of urinary tract infections in hospitalized patients with bacteriuria: The “Triple F” approach supported by Procalcitonin and …

…, C Janke, J Schneider, H Schneider, K Braitsch… - Plos one, 2020 - journals.plos.org
For acute medicine physicians, distinguishing between asymptomatic bacteriuria (ABU) and
clinically relevant urinary tract infections (UTI) is challenging, resulting in overtreatment of …

[HTML][HTML] P510: PREDICTORS OF RESPONSE AND OUTCOME IN PATIENTS WITH REFRACTORY/RELAPSED ACUTE MYELOID LEUKEMIA RECEIVING …

…, M Wichmann, R Gabdoulline, K Götze, K Braitsch… - …, 2023 - journals.lww.com
Background: Relapsed/refractory (R/R) acute myeloid leukemia (AML) is a largely unmet
medical condition with limited treatment options and dismal prognosis. In newly diagnosed …

[HTML][HTML] Genotype and Intensive Pretreatment Influence Outcome of Acute Myeloid Leukemia Patients Treated With Venetoclax in Combination With Hypomethylating …

K Braitsch, LK Schmalbrock, P Jung, I Bumeder… - …, 2022 - journals.lww.com
The B-cell lymphoma-2 inhibitor venetoclax (VEN) combined with hypomethylating agents (HMA)
or low-dose cytarabine (LDAC) has shown encouraging results in acute myeloid …

[HTML][HTML] Non-Hodgkin Lymphoma Secondary to Hodgkin Lymphoma in an Adult Patient With Nijmegen Breakage Syndrome

K Braitsch, T Vag, J Slotta-Huspenina, U Keller - HemaSphere, 2018 - journals.lww.com
Nijmegen breakage syndrome (NBS) is a rare inherited autosomal recessive DNA repair
disorder characterized by microcephaly, growth and mental retardation, immunodeficiency, …